Legraverend M, Ngongo-Tekam R M, Bisagni E, Zerial A
J Med Chem. 1985 Oct;28(10):1477-80. doi: 10.1021/jm00148a017.
5-Allyl-2-amino-4,6-dihydroxypyrimidine (3) was chlorinated and ozonized to yield (2-amino-4,6-dichloro-pyrimidin-5-yl)acetaldehyde (5). Acetalization of 5 with ethanol afforded a new pyrimidine intermediate 6 which can lead to 2-amino-3,4-dihydro-7-alkyl-7H-pyrrolo[2,3-d]pyrimidin-4-ones and therefore to carbocyclic analogues of 7-deazaguanosine. The 7-substituent was a cyclopentyl analogue of the arabinofuranosyl moiety in 10a, lyxofuranosyl moiety in 10b, and ribofuranosyl moiety in 10c. Compounds 10a and 10b exhibited selective inhibitory activities against the multiplication of HSV1 and HSV2 in cell culture. Repeated administration of compound 10a at 10mg/kg ip to mice infected with HSV2 increased the number of survivors and lengthened significantly the mean survival time.
5-烯丙基-2-氨基-4,6-二羟基嘧啶(3)经氯化和臭氧氧化生成(2-氨基-4,6-二氯嘧啶-5-基)乙醛(5)。5与乙醇进行缩醛化反应得到一种新的嘧啶中间体6,该中间体可生成2-氨基-3,4-二氢-7-烷基-7H-吡咯并[2,3-d]嘧啶-4-酮,进而得到7-脱氮鸟苷的碳环类似物。7-取代基在10a中是阿拉伯呋喃糖基部分的环戊基类似物,在10b中是来苏糖呋喃糖基部分,在10c中是核糖呋喃糖基部分。化合物10a和10b在细胞培养中对HSV1和HSV2的增殖表现出选择性抑制活性。以10mg/kg腹腔注射的方式对感染HSV2的小鼠重复给药化合物10a,可增加存活小鼠数量,并显著延长平均存活时间。